SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
24-Aug-21 7:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-21 | Payment of Exercise | 4,307 | $14.05 | $60,513.40 | (2%) 282.14K to 277.83K | (< 1%) |
24-May-21 6:18 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-21 | Payment of Exercise | 4,310 | $17.80 | $76,718.00 | (2%) 286.45K to 282.14K | 2% |
23-Feb-21 6:15 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-21 | Payment of Exercise | 31,869 | $18.79 | $598,819.00 | (10%) 316.92K to 285.05K | 4% |
10-Feb-21 5:51 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Feb-21 | Grant | 65,000 | -- | -- | 26% 251.92K to 316.92K | |
24-Nov-20 6:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-20 | Payment of Exercise | 4,807 | $17.21 | $82,728.50 | (2%) 256.72K to 251.92K | (9%) |
24-Aug-20 6:34 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-20 | Payment of Exercise | 4,804 | $18.22 | $87,528.90 | (2%) 261.53K to 256.72K | (3%) |
22-May-20 6:11 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-20 | Payment of Exercise | 4,807 | $26.67 | $128,203.00 | (2%) 266.33K to 261.53K | 30% |
24-Feb-20 7:13 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-20 | Payment of Exercise | 29,402 | $25.90 | $761,512.00 | (10%) 294.33K to 264.93K | 28% |
05-Feb-20 7:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-Feb-20 | Grant | 119,000 | -- | -- | 68% 175.33K to 294.33K | |
22-Nov-19 6:25 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-19 | Payment of Exercise | 3,567 | $17.60 | $62,779.20 | (2%) 178.9K to 175.33K | (7%) |
22-Aug-19 6:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-19 | Payment of Exercise | 3,084 | $21.51 | $66,336.80 | (2%) 181.99K to 178.9K | 13% |
22-May-19 6:15 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-19 | Payment of Exercise | 2,488 | $19.84 | $49,361.90 | (1%) 184.47K to 181.99K | 5% |
22-Feb-19 6:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-19 | Payment of Exercise | 5,798 | $27.00 | $156,546.00 | (3%) 189.24K to 183.45K | 31% |
07-Feb-19 5:49 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-19 | Grant | 112,250 | -- | -- | 146% 76.99K to 189.24K | |
21-Nov-18 5:46 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-18 | Payment of Exercise | 7,006 | $24.79 | $173,679.00 | (8%) 84.0K to 76.99K | |
29-Aug-18 6:24 PM View: | Theravance Biopharma, Inc. (TBPH) | 27-Aug-18 | Sale | 7,119 | $27.71 | $197,282.00 | (8%) 91.12K to 84.0K | |
22-Aug-18 7:34 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-18 | Payment of Exercise | 7,005 | $26.95 | $188,785.00 | (7%) 98.12K to 91.12K | |
09-Aug-18 7:46 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Aug-18 | Sale | 25,355 | $27.85 | $706,182.00 | (21%) 123.48K to 98.12K | |
09-Aug-18 7:46 PM View: | Theravance Biopharma, Inc. (TBPH) | 07-Aug-18 | Sale | 5,945 | $28.33 | $168,393.00 | (5%) 129.42K to 123.48K | |
08-Jun-18 7:34 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-Jun-18 | Sale | 3,900 | $23.66 | $92,260.00 | (3%) 133.32K to 129.42K | |
08-Jun-18 7:34 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Jun-18 | Sale | 10,140 | $24.09 | $244,268.00 | (7%) 143.46K to 133.32K | |
22-May-18 7:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-18 | Payment of Exercise | 21,812 | $24.31 | $530,250.00 | (13%) 165.28K to 143.46K | |
16-May-18 7:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-May-18 | Grant | 33,750 | -- | -- | 26% 131.53K to 165.28K | |
22-Feb-18 5:41 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-18 | Payment of Exercise | 5,587 | $29.09 | $162,526.00 | (4%) 136.25K to 130.66K | |
14-Feb-18 6:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 12-Feb-18 | Grant | 9,000 | -- | -- | 7% 127.25K to 136.25K | |
22-Nov-17 4:40 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-17 | Payment of Exercise | 7,079 | $28.58 | $202,318.00 | (5%) 134.33K to 127.25K | |
08-Sep-17 6:53 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Sep-17 | Sale | 14,670 | $30.77 | $451,350.00 | (10%) 149.0K to 134.33K | |
22-Aug-17 6:30 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-17 | Payment of Exercise | 7,079 | $27.40 | $193,965.00 | (5%) 156.08K to 149.0K | |
23-May-17 8:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-17 | Payment of Exercise | 7,079 | $36.83 | $260,720.00 | (4%) 163.16K to 156.08K | |
07-Mar-17 7:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-Mar-17 | Sale | 26,829 | $31.86 | $854,772.00 | (14%) 188.28K to 161.45K | |
22-Feb-17 7:07 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-17 | Payment of Exercise | 12,440 | $33.78 | $420,223.00 | (6%) 200.72K to 188.28K | |
08-Feb-17 7:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Feb-17 | Grant | 9,000 | -- | -- | 5% 191.72K to 200.72K | |
22-Nov-16 6:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-16 | Payment of Exercise | 4,008 | $31.96 | $128,096.00 | (2%) 195.73K to 191.72K | |
22-Aug-16 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 22-Aug-16 | Sale | 37,078 | $27.16 | $1,007,040.00 | (16%) 232.81K to 195.73K | |
22-Aug-16 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-16 | Payment of Exercise | 4,008 | $27.89 | $111,783.00 | (2%) 236.82K to 232.81K | |
22-Aug-16 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 19-Aug-16 | Sale | 4,870 | $28.14 | $137,042.00 | (2%) 241.69K to 236.82K | |
22-Aug-16 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 18-Aug-16 | Sale | 7,174 | $28.55 | $204,818.00 | (3%) 248.86K to 241.69K | |
24-May-16 8:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-16 | Payment of Exercise | 4,008 | $20.55 | $82,364.40 | (2%) 252.87K to 248.86K | |
17-Mar-16 7:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-Mar-16 | Grant | 115,000 | -- | -- | 84% 136.16K to 251.16K | |
23-Feb-16 7:59 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-16 | Payment of Exercise | 18,920 | $15.65 | $296,098.00 | (12%) 155.09K to 136.16K | |
24-Nov-15 7:37 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-15 | Payment of Exercise | 934 | $17.17 | $16,036.80 | (< 1%) 156.02K to 155.09K | |
24-Aug-15 7:10 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-15 | Payment of Exercise | 934 | $12.98 | $12,123.30 | (< 1%) 156.95K to 156.02K | |
04-Jun-15 7:14 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-Jun-15 | Payment of Exercise | 7,360 | $13.83 | $101,789.00 | (4%) 164.31K to 156.95K | |
22-May-15 7:16 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-15 | Payment of Exercise | 673 | $14.24 | $9,583.52 | (< 1%) 164.99K to 164.31K | |
24-Feb-15 6:55 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-15 | Payment of Exercise | 674 | $19.52 | $13,156.50 | (< 1%) 163.76K to 163.09K | |
09-Feb-15 8:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-15 | Grant | 120,000 | -- | -- | 274% 43.76K to 163.76K | |
24-Nov-14 7:02 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-14 | Payment of Exercise | 660 | -- | -- | (3%) 26.38K to 25.72K | |
22-Aug-14 5:01 PM View: | Theravance Inc. (INVA) | 20-Aug-14 | Payment of Exercise | 3,261 | $22.76 | $74,220.40 | (< 1%) 446.27K to 443.01K | 42% |
13-Aug-14 7:02 PM View: | Theravance Inc. (INVA) | 12-Aug-14 | Market Option Sale | 1,048 | $22.30 | $23,370.40 | (< 1%) 450.07K to 449.02K | 41% |
13-Aug-14 7:02 PM View: | Theravance Inc. (INVA) | 11-Aug-14 | Option Exercise | 33,667 | $14.53 | $489,182.00 | 8% 443.51K to 477.18K |